Supplier
Accredo Health Group INC
Accredo Health Group INC was paid $130.92M by Medicaid between Jan 2018 and Dec 2024, across 33 billing codes. Its largest line is J3285, Injection, treprostinil, 1 mg — 42% of everything it billed.
33Billing provider infoACCREDO HEALTH GROUP INC
WARRENDALE, PA 15086
WARRENDALE, PA 15086
33aNPI1417915653assigned 05/03/2006
33bProvider typeCommunity/Retail Pharmacy
28Total paid$130.92M
24GClaims150,809
24DCodes billed33
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community/Retail Pharmacy providers in Pennsylvania
Rank by total paid#2 of 44
Median peer was paid$461.37
This provider vs. median283,769×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PERINI, VIC controls 16+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,462 | $21.53M | |
| 2019 | 22,884 | $18.93M | |
| 2020 | 24,830 | $21.00M | |
| 2021 | 23,829 | $22.53M | |
| 2022 | 23,683 | $23.49M | |
| 2023 | 19,534 | $13.13M | |
| 2024incomplete | 11,587 | $10.31M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J3285 | Injection, treprostinil, 1 mg | 42% | 12,885 | 7,388 | $55.30M |
| J7686 | Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg | 9.5% | 3,664 | 2,682 | $12.48M |
| J1559 | Injection, immune globulin (hizentra), 100 mg | 9.4% | 9,258 | 4,885 | $12.37M |
| J7170 | Injection, emicizumab-kxwh, 0.5 mg | 8.1% | 824 | 495 | $10.65M |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 7.3% | 5,807 | 2,837 | $9.62M |
| J1325 | Injection, epoprostenol, 0.5 mg | 3.8% | 6,735 | 3,346 | $4.93M |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 3.7% | 2,902 | 1,260 | $4.90M |
| J1555 | Injection, immune globulin (cuvitru), 100 mg | 3.2% | 2,666 | 1,451 | $4.18M |
| S9347 | Home infusion therapy, uninterrupted, long-term, controlled rate intravenous or subcutaneous infusion therapy (e.g., epoprostenol); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem | 3.1% | 14,617 | 3,862 | $4.10M |
| J7192 | Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified | 2.3% | 1,123 | 252 | $3.01M |
| J1575 | Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin | 2.3% | 1,889 | 901 | $2.98M |
| J7340 | Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml | 1.4% | 1,596 | 1,131 | $1.81M |
21 more codes
| A4222 | Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately) | <1% | 14,396 | $953K |
| A4221 | Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately) | <1% | 30,168 | $668K |
| S9338 | Home infusion therapy, immunotherapy, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem | <1% | 6,718 | $586K |
| S9379 | Home infusion therapy, infusion therapy, not otherwise classified; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem | <1% | 5,821 | $467K |
| 99601 | <1% | 4,186 | $464K | |
| Q9992 | Injection, buprenorphine extended-release (sublocade), greater than 100 mg | <1% | 210 | $359K |
| 99602 | Nursing care in home rn | <1% | 1,874 | $306K |
| K0455 | Infusion pump used for uninterrupted parenteral administration of medication, (e.g., epoprostenol or treprostinol) | <1% | 7,062 | $249K |
| Q2052 | Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig) | <1% | 1,810 | $119K |
| Q0513 | Pharmacy dispensing fee for inhalation drug(s); per 30 days | <1% | 2,183 | $108K |
| E0781 | Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient | <1% | 1,919 | $99K |
| K0552 | Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each | <1% | 7,729 | $87K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 39 | $39K |
| S9999 | Sales tax | <1% | 403 | $39K |
| J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | <1% | 22 | $17K |
| S9346 | Home infusion therapy, alpha-1-proteinase inhibitor (e.g., prolastin); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem | <1% | 259 | $12K |
| S0155 | Sterile dilutant for epoprostenol, 50 ml | <1% | 35 | $10K |
| E0779 | Ambulatory infusion pump, mechanical, reusable, for infusion 8 hours or greater | <1% | 1,341 | $6K |
| E0574 | Ultrasonic/electronic aerosol generator with small volume nebulizer | <1% | 595 | $3K |
| S9357 | Home infusion therapy, enzyme replacement intravenous therapy; (e.g., imiglucerase); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem | <1% | 17 | $1K |
| A7016 | Dome and mouthpiece, used with small volume ultrasonic nebulizer | <1% | 56 | $45.71 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPERINI, VIC (ASSISTANT SECRETARY)
| Provider | Location | Paid |
|---|---|---|
| Accredo Health Group INC | Memphis, TN | $165.63M |
| Accredo Health Group INC | Irving, TX | $27.68M |
| Accredo Health Group INC | Corona, CA | $20.28M |
| Accredo Health Group INC | Tempe, AZ | $9.15M |
| Accredo Health Group INC | Lenexa, KS | $945K |
| Accredo Health Group INC | Marlborough, MA | $480K |
| Accredo Health Group INC | Las Vegas, NV | $480K |
| Accredo Health Group INC | New Orleans, LA | $266K |
| Accredo Health Group INC | Hoover, AL | $247K |
| Accredo Health Group INC | Greensboro, NC | $243K |
| Accredo Health Group INC | Oklahoma City, OK | $174K |
| Accredo Health Group INC | Novi, MI | $33K |
| Accredo Health Group INC | Pine Brook, NJ | $17K |
| Accredo Health Group INC | Englewood, CO | $6K |
| Accredo Health Group INC | Elmhurst, IL | $3K |
| Accredo Health Group INC | Norcross, GA | $481.79 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.